You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 13, July 14, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Urinary Tract Disorders
 •Drug Therapy
 •Drug Therapy, Other
 •Emergency Medicine
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Appropriateness of Fluoroquinolones for Therapy of Urinary Tract Infection

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Inappropriate use of antibiotics, particularly of vital agents such as fluoroquinolones, is important to recognize and avoid. The recent report by Lautenbach et al1 addressed this need by providing potentially useful data regarding inappropriate use of fluoroquinolones in emergency departments. However, this report leaves uncertainty as to the actual appropriateness of use, particularly with respect to treatment of urinary tract infection, which was the single most common indication for fluoroquinolone therapy in the study. The only stated criterion for appropriate fluoroquinolone use for therapy of urinary tract infection was allergy to the first-line agent, trimethoprim-sulfamethoxazole (TMP-SMZ). However, depending on the local prevalence of resistance to TMP-SMZ among uropathogens in general, or Escherichia coli in particular, alternative therapy (including a fluoroquinolone) actually would be appropriate, according to recent national guidelines.2 It would be of interest to know the relevant resistance prevalence data for the participating centers. Other factors that might favor . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Fluoroquinolone Utilization in the Emergency Departments of Academic Medical Centers: Prevalence of, and Risk Factors for, Inappropriate Use
Ebbing Lautenbach, Lori A. Larosa, Nishaminy Kasbekar, Helen P. Peng, Richard J. Maniglia, and Neil O. Fishman
Arch Intern Med. 2003;163(5):601-605.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.